Options for calming anxiety range from over-the-counter supplements with modest evidence behind them to prescription medications with decades of clinical-trial data. A handful of herbal preparations, particularly lavender oil extract and ashwagandha, have performed surprisingly well in randomized trials, while first-line prescriptions like SSRIs remain the most robustly studied treatments. Where you start on that spectrum depends on how severe your anxiety is, whether you have a formal diagnosis, and what side-effect trade-offs you’re willing to accept.
Herbal Supplements That Have Actual Trial Data
Most herbal supplements marketed for anxiety have thin evidence, but a few stand out with real randomized controlled trials behind them. The strongest case belongs to Silexan, a standardized lavender oil capsule. A meta-analysis of placebo-controlled trials found its effect size comparable to that of SSRIs and SNRIs, which are the frontline prescription treatments for anxiety disorders.1PubMed Central. Efficacy of Silexan in patients with anxiety disorders: a meta-analysis of randomized, placebo-controlled trials In a head-to-head trial against lorazepam (a benzodiazepine), Silexan reduced anxiety scores by about 45%, virtually identical to lorazepam’s 46% reduction.2PubMed. A multi-center, double-blind, randomised study of the Lavender oil preparation Silexan in comparison to Lorazepam for generalized anxiety disorder A separate trial comparing Silexan at two doses against the SSRI paroxetine found the higher lavender dose outperformed paroxetine on the primary anxiety measure, while paroxetine only trended toward significance against placebo.3International Journal of Neuropsychopharmacology. Lavender oil preparation Silexan is effective in generalized anxiety disorder – a randomized, double-blind comparison to placebo and paroxetine These are remarkable results for a plant extract, though it’s worth noting that Silexan is a pharmaceutical-grade preparation, not the lavender essential oil you’d find at a health food store.
Ashwagandha has accumulated solid evidence as well. A systematic review and meta-analysis found it significantly reduced anxiety on standard clinical scales at eight weeks of supplementation, while also lowering cortisol levels and perceived stress.4PubMed Central. Effects of Ashwagandha Supplements on Cortisol, Stress, and Anxiety Levels in Adults: A Systematic Review and Meta-Analysis Individual trials have confirmed this pattern, with one showing reduced anxiety scores and lower morning cortisol compared to placebo.5PubMed Central. An investigation into the stress-relieving and pharmacological actions of an ashwagandha (Withania somnifera) extract Ashwagandha appears to work partly by dampening the body’s stress-hormone response, which makes it a reasonable option for people whose anxiety is closely tied to chronic stress.
Passionflower (Passiflora incarnata) has shown reduced anxiety levels across most studies that have tested it, though the effect is less clear in people who start with only mild symptoms.6PubMed Central. Passiflora incarnata in Neuropsychiatric Disorders—A Systematic Review Chamomile is in a similar category: a systematic review of clinical trials concluded that daily oral chamomile can improve anxiety symptoms across various groups, including people with diagnosed anxiety disorders and those dealing with situational anxiety like menstrual-cycle distress or recovery from illness.7Clinical Nutrition Research. The Effect of Oral Chamomile on Anxiety: A Systematic Review of Clinical Trials Neither herb is likely to match the potency of Silexan or ashwagandha, but both appear safe for most people and can be a reasonable first step.
The Kava Question
Kava deserves its own discussion because it occupies an awkward middle ground: it works, but it carries risks that other herbal options don’t. Across clinical trials, kava has shown a large effect size for reducing anxiety, with significant benefits in the majority of studies.8PubMed. Kava: a comprehensive review of efficacy, safety, and psychopharmacology A pooled analysis of responder rates from five trials found kava roughly 50% more likely to produce a positive response than placebo, with side-effect rates comparable to placebo in most studies.9PubMed. The effectiveness and safety of Kava Kava for treating anxiety symptoms: A systematic review and analysis of randomized clinical trials
The concern is liver damage. Published case reports have linked kava to serious hepatotoxicity, and some countries have restricted or banned its sale at various points. A systematic review of safety data found that adverse events during short-term use at recommended doses are generally rare, mild, and reversible, but that serious reactions, including liver injury, are possible.10PubMed. A systematic review of the safety of kava extract in the treatment of anxiety If you use kava, sticking to traditional water-based root extracts (rather than solvent-extracted supplements), avoiding alcohol, and getting periodic liver-function checks are all sensible precautions.8PubMed. Kava: a comprehensive review of efficacy, safety, and psychopharmacology
Amino Acids, Minerals, and Vitamins
L-theanine, an amino acid found naturally in tea, promotes a measurable relaxation response in the brain. A crossover trial found that a single dose increased alpha brain-wave activity in the frontal region, a pattern associated with calm wakefulness, while simultaneously lowering salivary cortisol compared to placebo within an hour.11PubMed Central. A Randomized, Triple-Blind, Placebo-Controlled, Crossover Study to Investigate the Efficacy of a Single Dose of AlphaWave® L-Theanine on Stress in a Healthy Adult Population L-theanine won’t eliminate a panic attack, but for everyday stress and tension it’s one of the better-supported over-the-counter options, with virtually no side effects at typical doses.
Magnesium plays an inhibitory role in the body’s stress response, helping to regulate the neurotransmitters that ramp up when you’re anxious. Research has found that low magnesium status is common among people experiencing psychological stress, and that stress itself can deplete magnesium, creating a feedback loop where deficiency worsens anxiety and anxiety worsens deficiency.12PubMed Central. Magnesium Status and Stress: The Vicious Circle Concept Revisited Correcting a deficiency through supplementation makes physiological sense, though the evidence is stronger for people who are actually low in magnesium than for those who already have adequate levels.
Vitamin D deficiency has been linked to a higher risk of both depression and anxiety, and people with these conditions tend to have lower serum levels of it.13PubMed Central. Molecular Basis Underlying the Therapeutic Potential of Vitamin D for the Treatment of Depression and Anxiety A systematic review of randomized trials found that vitamin D supplementation, when used as an add-on to standard treatment, improved anxiety symptoms, though the available evidence for anxiety specifically is more limited than for depression.14PubMed. Efficacy of B-vitamins and vitamin D therapy in improving depressive and anxiety disorders: a systematic review of randomized controlled trials B vitamins, particularly folate and B12, showed stronger effects for depression than anxiety in the same review. The upshot: if your anxiety coexists with low vitamin D or B-vitamin levels, correcting those gaps may help. If your levels are already normal, megadosing is unlikely to move the needle.
CBD and Cannabinoids
CBD has generated enormous consumer interest for anxiety, but the clinical evidence is thinner than the marketing suggests. Preclinical research and early human trials indicate that CBD has potential as an anxiolytic, particularly for social anxiety.15PubMed Central. Cannabidiol as a Potential Treatment for Anxiety Disorders A systematic review found that single-dose CBD pretreatment reduced anxiety in lab settings among people with social anxiety disorder, and a four-week daily CBD trial in adolescents with social anxiety showed modest improvements.16PubMed Central. Evidence for Use of Cannabinoids in Mood Disorders, Anxiety Disorders, and PTSD: A Systematic Review
“Modest” and “preliminary” are the operative words here. The studies are small, the optimal dose is unclear, product quality varies wildly since CBD is not regulated the way pharmaceuticals are, and long-term data is essentially nonexistent. A synthesis of pre-clinical and clinical evidence describes the current state as “preliminary” and calls for more rigorous trials.17PubMed Central. Use of Cannabidiol for the Treatment of Anxiety: A Short Synthesis of Pre-Clinical and Clinical Evidence CBD is unlikely to harm you at moderate doses, but paying premium prices for an unregulated product based on a handful of small studies is a gamble worth being clear-eyed about.
Prescription Medications for Anxiety
When anxiety is persistent, significantly interfering with daily life, or meets the threshold for a clinical diagnosis, prescription medications become the evidence-based standard. The first-line options are SSRIs and SNRIs, a class of antidepressants that also work well for anxiety disorders. A meta-analysis examining dose-response relationships confirmed their effectiveness, noting that higher SSRI doses within the therapeutic range tend to produce greater benefit, while SNRI doses above the starting range don’t add much.18PubMed. Systematic review and meta-analysis: Dose-response curve of SSRIs and SNRIs in anxiety disorders These medications take several weeks to reach full effect, which is one of their practical downsides, but they address the underlying neurobiology of anxiety rather than just masking symptoms.
Benzodiazepines like lorazepam, alprazolam, and clonazepam work fast and can be dramatically effective for acute anxiety. The medical community is deeply divided about their place in treatment, though. Recent years have brought a strong push toward deprescribing due to risks of dependence and misuse, while some clinicians argue the evidence supports their safety when used judiciously.19PubMed Central. Benzos (as) needed: research into as-needed and intermittent benzodiazepines for anxiety is required for comprehensive best prescribing practices What’s not debated is that physical dependence develops with regular use, and withdrawal can produce a syndrome of increased anxiety, insomnia, tremor, sweating, and other symptoms that typically peaks within about 10 to 14 days after stopping.20PubMed. The benzodiazepine withdrawal syndrome For most people, benzodiazepines make the most sense as a short-term bridge while waiting for an SSRI to take effect, or as a genuinely occasional tool for situational panic.
Buspirone offers a middle path. It was the first non-benzodiazepine anxiolytic approved for generalized anxiety disorder and works through a completely different mechanism than benzodiazepines, targeting serotonin receptors instead. It has a better safety profile, with fewer sedating and dependency-related side effects.21The Internet Journal of Pharmacology. Buspirone And Anxiety Disorders: A Review With Pharmacological And Clinical Perspectives The trade-off is that buspirone takes one to two weeks to start working and is mainly effective for generalized anxiety rather than panic disorder or social anxiety. People who’ve previously felt the immediate relief of a benzodiazepine sometimes find buspirone underwhelming, which isn’t really a fair comparison: they work on completely different timescales.
Beta-blockers, particularly propranolol, are sometimes used for performance anxiety and stage fright. They don’t treat the psychological component of anxiety directly but block the physical symptoms, the racing heart, trembling hands, and shaky voice that feed the anxiety loop. Propranolol is one of the very few medications with a specific track record for stage fright.22PubMed Central. Propranolol versus Other Selected Drugs in the Treatment of Various Types of Anxiety or Stress, with Particular Reference to Stage Fright and Post-Traumatic Stress Disorder It won’t help with the ruminating thoughts of generalized anxiety, but for a one-off presentation or audition, it can be remarkably effective.
Pregabalin, approved in some countries for generalized anxiety disorder, has shown efficacy for both acute treatment and relapse prevention, with some evidence that it starts working earlier than SSRIs do. It also helps as an add-on when an antidepressant alone isn’t doing enough.23PubMed Central. Pregabalin for the treatment of generalized anxiety disorder: an update Other second-line prescription options that have shown benefit in placebo-controlled trials for generalized anxiety include hydroxyzine (an antihistamine with sedating properties) and certain antipsychotics used at low doses, though these tend to be reserved for cases where first-line treatments have failed.24PubMed Central. Treatment of generalized anxiety disorder: a comprehensive review of the literature for psychopharmacologic alternatives to newer antidepressants and benzodiazepines
Herb-Drug Interactions You Should Know About
If you’re combining supplements with prescription anxiety medications, or any other prescriptions, interactions are a genuine concern. A review of clinically relevant herb-drug interactions identified 13 commonly used herbal products that can interfere with prescription neuropsychiatric drugs, including kava, valerian, ginkgo, ginseng, and St. John’s wort.25PubMed Central. Herb-drug Interactions in Neuropsychiatric Pharmacotherapy – A Review of Clinically Relevant Findings St. John’s wort is the most dangerous offender. It revs up the liver enzymes that break down dozens of medications, effectively reducing the blood levels of drugs ranging from SSRIs like paroxetine and sertraline to benzodiazepines like alprazolam and midazolam, oral contraceptives, blood thinners, and many others.26PubMed. Interactions between herbal medicines and prescribed drugs: an updated systematic review Kava can interact with alprazolam and certain other medications as well.26PubMed. Interactions between herbal medicines and prescribed drugs: an updated systematic review
The practical takeaway is straightforward: if you’re taking any prescription medication, tell your doctor or pharmacist about every supplement you use. This is especially true for St. John’s wort, which people sometimes take for mood without realizing it can undermine half their medicine cabinet.
Why Stopping Medications Requires a Plan
Coming off anxiety medications is not as simple as stopping them when you feel better. Benzodiazepine withdrawal, as noted earlier, can produce a cluster of symptoms that in some cases is more intense than the original anxiety. Even people on normal therapeutic doses can experience rebound anxiety within days of stopping, followed by a more prolonged withdrawal syndrome.20PubMed. The benzodiazepine withdrawal syndrome
SSRIs and SNRIs carry their own discontinuation issues. Withdrawal syndromes are common and can be severe, sometimes prompting people to restart the medication, which can be mistaken for a relapse of the underlying condition when it’s actually just withdrawal. Standard clinical guidelines have historically recommended short tapers of two to four weeks, but research suggests these are barely better than stopping abruptly. Slower tapers over months, gradually reducing to doses well below the minimum therapeutic level, have shown much better results.27The Lancet Psychiatry. Tapering of SSRI treatment to minimise discontinuation symptoms This is one area where the science has genuinely shifted in recent years, and many prescribers are now adopting slower, more individualized tapering schedules.
The Placebo Problem in Anxiety Research
Something worth keeping in mind as you evaluate any anxiety treatment: the placebo response in anxiety trials is enormous. A large meta-analysis found that people given sugar pills in anxiety-disorder trials improved by a substantial amount on average, with about 37% meeting criteria for “response” and about a quarter achieving full remission on placebo alone.28PubMed Central. Placebo response in trials with patients with anxiety, obsessive-compulsive and stress disorders across the lifespan: a three-level meta-analysis Generalized anxiety disorder, the most common form of clinical anxiety, had one of the highest placebo response rates of any anxiety diagnosis. High placebo response rates can mask real drug effects and complicate the interpretation of trials, particularly when studies aren’t designed rigorously.29PubMed. Placebo response in anxiety disorders
This doesn’t mean anxiety treatments don’t work. It means anxiety is unusually responsive to context: the act of enrolling in a study, receiving attention from clinicians, expecting to improve, and having a structured routine all reduce anxiety on their own. It also means that some of the supplements people swear by may be producing real benefits that are partly pharmacological and partly expectation-driven, and separating the two is harder in anxiety than in many other conditions. Federally funded studies and those with tighter designs tend to show lower placebo response, which makes the drug-versus-placebo difference clearer.30PubMed Central. Placebo Response in Pediatric Anxiety Disorders: Implications for Clinical Trial Design and Interpretation
Emerging Approaches Worth Watching
Two newer areas of research are generating cautious optimism. Ketamine, already approved in a nasal-spray form (esketamine) for treatment-resistant depression, is being studied for anxiety disorders as well. A meta-analysis of randomized trials concluded that acute ketamine may be broadly effective across treatment-resistant anxiety spectrum disorders, and that maintenance dosing can prolong the benefits.31PubMed Central. Systematic review and meta-analysis of randomized controlled trials of ketamine in the treatment of refractory anxiety spectrum disorders A more recent systematic review found that the anxiety-reducing effects are sustained with repeated doses, but symptoms tend to return after maintenance treatment stops, suggesting ketamine addresses symptoms rather than the root cause.32PubMed. Ketamine/esketamine pharmacotherapy for treatment of anxiety disorders and anxiety symptoms in depression: Systematic review Ketamine treatment is expensive, requires clinical supervision, and is currently off-label for anxiety, so it’s mainly relevant for people who haven’t responded to standard options.
Psychobiotics, specific strains of probiotics that influence brain function through the gut-brain axis, represent a very different angle. The concept is that certain Lactobacillus and Bifidobacterium strains can modulate neurotransmitter production, stress-hormone regulation, and immune signaling in ways that reduce anxiety and depression.33PubMed Central. The Role of Psychobiotics to Ensure Mental Health during the COVID-19 Pandemic-A Current State of Knowledge The current evidence suggests that specific strains can reduce symptoms, but the research is still working out which strains, at what doses, and for whom.34PubMed Central. Psychobiotics: Are they the future intervention for managing depression and anxiety? A literature review It’s too early to recommend a specific probiotic product for anxiety with any confidence, but the gut-brain connection is a legitimate area of science, not just wellness hype.
Matching the Treatment to the Problem
The sheer number of options can itself feel overwhelming, so it helps to think about severity and type. Mild, intermittent stress-related anxiety, the kind where you’re functional but on edge, is where supplements like L-theanine, ashwagandha, and chamomile are most reasonable to try. They have favorable safety profiles, don’t require a prescription, and carry enough evidence to be worth the experiment. Silexan (lavender oil extract) occupies a unique spot: supplement-level accessibility with prescription-level trial data, at least for generalized anxiety.
Moderate to severe anxiety, the kind that’s affecting your relationships, your work, or your ability to leave the house, is where prescription options earn their side effects. SSRIs and SNRIs remain the first-line recommendation for good reason: they have the deepest evidence base, treat most anxiety subtypes, and don’t carry dependence risk. Buspirone works for generalized anxiety with fewer side effects than SSRIs, though it’s less versatile. Benzodiazepines and beta-blockers serve specific situational roles but aren’t sustainable long-term daily treatments for most people.
Nutritional corrections, fixing a magnesium or vitamin D deficiency, are worth doing regardless of where you are on the severity spectrum, because they address a physiological contributor that can make any other treatment work better. And whatever you try, the unusually high placebo response in anxiety research is actually good news for you as a patient: it means that structured engagement with a treatment plan, any treatment plan, tends to help your brain calm down even before the active ingredient kicks in.